SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-083869
Filing Date
2023-11-06
Accepted
2023-11-06 16:03:22
Documents
14
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187794-8k_augmedix.htm   iXBRL 8-K 40165
2 PRESS RELEASE DATED NOVEMBER 6, 2023 ANNOUNCING THIRD QUARTER 2023 FINANCIAL RES ea187794ex99-1_augmedix.htm EX-99.1 95123
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9259
  Complete submission text file 0001213900-23-083869.txt   336427

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE augx-20231106.xsd EX-101.SCH 3015
5 XBRL LABEL FILE augx-20231106_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE augx-20231106_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT ea187794-8k_augmedix_htm.xml XML 3410
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 231379917
SIC: 7389 Services-Business Services, NEC